imatinib mesylate has been researched along with Peritoneal Diseases in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Akkar, OB; Cetin, A; Kacan, SB; Kacan, T; Karakus, S; Ozer, H; Seker, M; Yildiz, C | 1 |
| Kondo, H; Motohara, T; Ohira, N; Oku, T; Shikishima, H; Sumiyoshi, T; Takayama, T; Waga, E; Yoshizaki, N | 1 |
2 other study(ies) available for imatinib mesylate and Peritoneal Diseases
| Article | Year |
|---|---|
Effect of imatinib on growth of experimental endometriosis in rats.
Topics: Anastrozole; Angiogenesis Inhibitors; Animals; Aromatase Inhibitors; bcl-2-Associated X Protein; Cell Proliferation; Disease Models, Animal; Endometriosis; Endometrium; Female; Imatinib Mesylate; Nitriles; Ovarian Follicle; Peritoneal Diseases; Peritoneum; Proto-Oncogene Proteins c-kit; Rats; Transplantation, Autologous; Triazoles; Vascular Endothelial Growth Factor A | 2016 |
[A case of primary small intestinal gastrointestinal stromal tumor: an intraperitoneal bleeding from greater omentum metastasis caused by administration of imatinib mesylate].
Topics: Aged; Antineoplastic Agents; Benzamides; Gastrointestinal Neoplasms; Hemorrhage; Humans; Imatinib Mesylate; Intestine, Small; Male; Omentum; Peritoneal Diseases; Peritoneal Neoplasms; Piperazines; Pyrimidines; Stromal Cells | 2003 |